Jin‐Jian Lu

14.7k total citations · 2 hit papers
237 papers, 9.8k citations indexed

About

Jin‐Jian Lu is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Jin‐Jian Lu has authored 237 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Molecular Biology, 39 papers in Oncology and 34 papers in Pharmacology. Recurrent topics in Jin‐Jian Lu's work include Autophagy in Disease and Therapy (26 papers), Natural product bioactivities and synthesis (25 papers) and Traditional Chinese Medicine Analysis (21 papers). Jin‐Jian Lu is often cited by papers focused on Autophagy in Disease and Therapy (26 papers), Natural product bioactivities and synthesis (25 papers) and Traditional Chinese Medicine Analysis (21 papers). Jin‐Jian Lu collaborates with scholars based in Macao, China and United States. Jin‐Jian Lu's co-authors include Xiuping Chen, Yitao Wang, Yitao Wang, Jiaolin Bao, Mingqing Huang, Jian Ding, Min Huang, Zhenghai Tang, Xiuping Chen and Lele Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biomaterials.

In The Last Decade

Jin‐Jian Lu

228 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural Products in Cancer Therapy: Past, Present and Future

2021 449 citations Jin‐Jian Lu et al. profile →
Anti-cancer natural products isolated from chinese medicinal herbs

2011 328 citations Jin‐Jian Lu, Mingqing Huang et al. profile →

Peers

Countries citing papers authored by Jin‐Jian Lu

Since Specialization

Citations

This map shows the geographic impact of Jin‐Jian Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin‐Jian Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin‐Jian Lu more than expected).

Fields of papers citing papers by Jin‐Jian Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin‐Jian Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin‐Jian Lu. The network helps show where Jin‐Jian Lu may publish in the future.

Co-authorship network of co-authors of Jin‐Jian Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Jin‐Jian Lu. A scholar is included among the top collaborators of Jin‐Jian Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin‐Jian Lu. Jin‐Jian Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gut Microbiota and Bile Acid Metabolism in the Mechanism of Ginsenoside Re Against Nonalcoholic Fatty Liver Disease 2025 ·Phytotherapy Research ·Yanfang Zheng, (unknown), Ying Zhang, (unknown), (unknown), Dennis Chang, Yitao Wang, Jin‐Jian Lu, Xian Zhou, Qin Xie, (unknown), (unknown)	2
2	Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin‐mediated Phagocytic Effects for Lung Cancer Treatment 2025 ·Advanced Science ·Zihan Ye, Wei‐Bang Yu, Mu‐Yang Huang, Yanyan Chen, Lele Zhang, (unknown), Xiaolei Zhang, Zhenghai Tang, Ting Li, Jin‐Jian Lu	0
3	Maresin2 negatively regulates DC’s maturation via the MAPK/NF-κB pathway in DCs 2024 ·International Immunopharmacology ·Chaoqun Wang, Jiewen Deng, (unknown), (unknown), Zhenhong Guo, Jin‐Jian Lu	1
4	Beyond cancer: The potential application of CD47-based therapy in non-cancer diseases 2024 ·Acta Pharmaceutica Sinica B ·(unknown), (unknown), Zhenghai Tang, Xiaolei Zhang, Jin‐Jian Lu	0
5	Mechanism-oriented quality research system for traditional Chinese medicine 2024 ·Scientia Sinica Vitae ·Shengpeng Wang, (unknown), Xiuping Chen, Li Peng, Jiahong Lu, Jin‐Jian Lu, (unknown), (unknown), Yingjie Zheng, Wei Zhang, Zhihong Jiang, Xin Chen	1
6	Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma 2024 ·Acta Pharmacologica Sinica ·Qiyi Zhang, Wen Ding, Jianshan Mo, Shumin Ouyang, (unknown), (unknown), (unknown), Jin‐Jian Lu, Peibin Yue, Jinping Lei, Yan‐Dong Wang, Xiaolei Zhang	8
7	Phytochemical compositions and biological activities of the branches and leaves of Ormosia hosiei Hemsl. et Wils. 2023 ·Journal of Pharmaceutical and Biomedical Analysis ·Yifan Lin, Shaohua Li, Tao Chen, (unknown), (unknown), Lin Ni, Jin‐Jian Lu, Mingqing Huang	2
8	Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer 2023 ·Cancer Research ·Ziyou Lin, (unknown), Jian Zhang, Weineng Feng, Jiaye Lu, (unknown), (unknown), Shumin Ouyang, Jin‐Jian Lu, Peibin Yue, Guohui Wan, Peiqing Liu, Xiaolei Zhang	75
9	Nifuroxazide boosts the anticancer efficacy of palbociclib-induced senescence by dual inhibition of STAT3 and CDK2 in triple-negative breast cancer 2023 ·Cell Death Discovery ·(unknown), (unknown), Xumei Wang, Jin‐Jian Lu, Ping He, Hongjie Zhang, Xiuping Chen	11
10	Nitrovin (difurazone), an antibacterial growth promoter, induces ROS-mediated paraptosis-like cell death by targeting thioredoxin reductase 1 (TrxR1) 2023 ·Biochemical Pharmacology ·Lin Zhao, Bingling Zhong, Yanyan Zhu, Haoyi Zheng, Xumei Wang, Ying Hou, Jin‐Jian Lu, Nana Ai, Xiuli Guo, Wei Ge, Yanyan Ma, Xiuping Chen	15
11	Nannocystin ax, an eEF1A inhibitor, induces G1 cell cycle arrest and caspase-independent apoptosis through cyclin D1 downregulation in colon cancer in vivo 2021 ·Pharmacological Research ·Ying Hou, Rong Liu, (unknown), (unknown), Bingling Zhong, Jie Yu, Nana Ai, Jin‐Jian Lu, Wei Ge, Bo Liu, Xiuping Chen	20
12	iNOS Interacts with Autophagy Receptor p62 and is Degraded by Autophagy in Macrophages 2019 ·Cells ·Jing Wang, Mingyue Wu, Huanxing Su, Jin‐Jian Lu, Xiuping Chen, Jieqiong Tan, Jiahong Lu	25
13	Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation 2019 ·Phytomedicine ·Cui-Zan Cai, Hefeng Zhou, Ningning Yuan, Mingyue Wu, Simon Ming‐Yuen Lee, Jiaoyan Ren, Huanxing Su, Jin‐Jian Lu, Xiuping Chen, Min Li, Jieqiong Tan, Jiahong Lu	37
14	Nagilactone E suppresses TGF-β1-induced epithelial–mesenchymal transition, migration and invasion in non-small cell lung cancer cells 2018 ·Phytomedicine ·Lele Zhang, Xiaoming Jiang, Mu‐Yang Huang, Zheling Feng, Xiuping Chen, Yitao Wang, Hua Li, Ao Li, Ligen Lin, Jin‐Jian Lu	18
15	Inhibition of Lung Cancer by 2-Methoxy-6-Acetyl-7-Methyljuglone Through Induction of Necroptosis by Targeting Receptor-Interacting Protein 1 2018 ·Antioxidants and Redox Signaling ·Wen Sun, Jie Yu, Hongwei Gao, Xiaxia Wu, Sheng Wang, Ying Hou, Jin‐Jian Lu, Xiuping Chen	33
16	PTEN Activation by DNA Damage Induces Protective Autophagy in Response to Cucurbitacin B in Hepatocellular Carcinoma Cells 2016 ·Oxidative Medicine and Cellular Longevity ·Yanan Niu, Wen Sun, Jin‐Jian Lu, Dik‐Lung Ma, Chung‐Hang Leung, Lixia Pei, Xiuping Chen	30
17	The pharmacological effect and its underlying mcchanisms of toosendanin: A review 2016 ·(unknown), Jin‐Jian Lu, Xiuping Chen, Jian‐Bo Wan	1
18	Development of Monoclonal Antibodies in China: Overview and Prospects 2015 ·BioMed Research International ·Maoyu Zhang, Jin‐Jian Lu, Liang Wang, (unknown), Hao Hu, Carolina Oi Lam Ung, Yitao Wang	9
19	Baicalein Triggers Autophagy and Inhibits the Protein Kinase B/Mammalian Target of Rapamycin Pathway in Hepatocellular Carcinoma HepG2 Cells 2015 ·Phytotherapy Research ·Ya‐Fang Wang, Ting Li, Zhenghai Tang, Linlin Chang, Hong Zhu, Xiuping Chen, Yitao Wang, Jin‐Jian Lu	54
20	Protection of Total Flavonoid Fraction from Nervilia fordii on Lipopolysaccharide-induced Acute Lung Injury in Rats 2012 ·Chinese Herbal Medicines ·Mingqing Huang, Youliang Xie, Xiao‐Ping Lai, Ling Lin, (unknown), Jin‐Jian Lu, Xiuping Chen	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact